JPRN-jRCT1050210159进行中（未招募）未知
A retrospective, 12-month, multicenter study to evaluate real-world brolucizumab effectiveness and safety in Japanese patients with neovascular age-related macular degeneration (nAMD) - Pheasant Study
Takuma Okada0 个研究点目标入组 500 人开始时间: 2022年1月22日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- >= 50age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1.Diagnosis of nAMD
- •2.Patients with >= 50 years of age at index
- •3.Receipt of first injection of brolucizumab during the index period
- •4.Signed or Verbal informed consent
排除标准
- •1. Patients treated for RVO, DME, mCNV, and have diagnoses of diabetes-related macular degeneration within 6 months prior to the index date
- •2. Any active intraocular or periocular infection or active intraocular inflammation in the study eye at index date
- •3.Patients who have any contraindication and are not eligible for treatment with brolucizumab as according to the label
- •4. Patients who were treated with more than 3 types of anti-VEGF before index date (5th line brolucizumab patients or more)
- •5. Patients participating in parallel in an interventional clinical trial
- •Note: if a patient experiences an adverse event, they may still be recruited in another study following this adverse event if they fulfill their inclusion criteria. Their data will still be collected as planned by the current protocol
- •6. Patients participating in Post-Marketing surveillance with brolucizumab
研究者
相似试验
已完成
不适用
A multicenter retrospective observational study evaluating the safety and efficacy of immune checkpoint inhibitors in patients with advanced or recurrent lung cancer after COVID-19 vaccination (NEJ061)advanced or recurrent lung cancerJPRN-UMIN000048096Specified Nonprofit Corporation North East Japan Study Group850
尚未招募
不适用
COVID-19 pneumonia in patients with underlying fatty liverCTRI/2022/03/040908MAX Smart Super specialty Hospital A unit of Gujarmal Modi Hospital
招募中
不适用
The study on prognosis in patients with fatty liverJPRN-UMIN000046497Yokohama City University3,000
招募中
3 期
A Prospective, Multicenter, Long-Term Study to Assess the Safety and Efficacy of Nemolizumab (CD14152) in Subjects with Moderate-to-Severe Atopic Dermatitis.chronic skin inflammation10014982atopic dermatitisNL-OMON54779Galderma15
招募中
3 期
A Prospective, Multicenter, Long-Term Study to Assess the Safety and Efficacy of Nemolizumab (CD14152) in Subjects with Prurigo NodularisNL-OMON54290Galderma10